176 related articles for article (PubMed ID: 17685559)
1. Retrocyclin-2: structural analysis of a potent anti-HIV theta-defensin.
Daly NL; Chen YK; Rosengren KJ; Marx UC; Phillips ML; Waring AJ; Wang W; Lehrer RI; Craik DJ
Biochemistry; 2007 Sep; 46(35):9920-8. PubMed ID: 17685559
[TBL] [Abstract][Full Text] [Related]
2. Retrocyclin, an antiretroviral theta-defensin, is a lectin.
Wang W; Cole AM; Hong T; Waring AJ; Lehrer RI
J Immunol; 2003 May; 170(9):4708-16. PubMed ID: 12707350
[TBL] [Abstract][Full Text] [Related]
3. A theta-defensin composed exclusively of D-amino acids is active against HIV-1.
Owen SM; Rudolph D; Wang W; Cole AM; Sherman MA; Waring AJ; Lehrer RI; Lal RB
J Pept Res; 2004 Jun; 63(6):469-76. PubMed ID: 15175019
[TBL] [Abstract][Full Text] [Related]
4. Retrocyclin-2: a potent anti-HIV theta-defensin that forms a cyclic cystine ladder structural motif.
Daly NL; Chen YK; Rosengren KJ; Marx UC; Phillips ML; Waring AJ; Wang W; Lehrer RI; Craik DJ
Adv Exp Med Biol; 2009; 611():577-8. PubMed ID: 19400321
[No Abstract] [Full Text] [Related]
5. The theta-defensin, retrocyclin, inhibits HIV-1 entry.
Münk C; Wei G; Yang OO; Waring AJ; Wang W; Hong T; Lehrer RI; Landau NR; Cole AM
AIDS Res Hum Retroviruses; 2003 Oct; 19(10):875-81. PubMed ID: 14585219
[TBL] [Abstract][Full Text] [Related]
6. Theta defensins protect cells from infection by herpes simplex virus by inhibiting viral adhesion and entry.
Yasin B; Wang W; Pang M; Cheshenko N; Hong T; Waring AJ; Herold BC; Wagar EA; Lehrer RI
J Virol; 2004 May; 78(10):5147-56. PubMed ID: 15113897
[TBL] [Abstract][Full Text] [Related]
7. RC-101, a retrocyclin-1 analogue with enhanced activity against primary HIV type 1 isolates.
Owen SM; Rudolph DL; Wang W; Cole AM; Waring AJ; Lal RB; Lehrer RI
AIDS Res Hum Retroviruses; 2004 Nov; 20(11):1157-65. PubMed ID: 15588337
[TBL] [Abstract][Full Text] [Related]
8. Retrocyclin RC-101 overcomes cationic mutations on the heptad repeat 2 region of HIV-1 gp41.
Fuhrman CA; Warren AD; Waring AJ; Dutz SM; Sharma S; Lehrer RI; Cole AL; Cole AM
FEBS J; 2007 Dec; 274(24):6477-87. PubMed ID: 18028423
[TBL] [Abstract][Full Text] [Related]
9. Activity of alpha- and theta-defensins against primary isolates of HIV-1.
Wang W; Owen SM; Rudolph DL; Cole AM; Hong T; Waring AJ; Lal RB; Lehrer RI
J Immunol; 2004 Jul; 173(1):515-20. PubMed ID: 15210812
[TBL] [Abstract][Full Text] [Related]
10. Molecular dynamics study of the proposed beta-hairpin form of the switch domain from HIV1 gp120 alone and complexed with an inhibitor of CD4 binding.
Graf von Stosch A; von der Lieth CW; Reed J
Proteins; 1999 Feb; 34(2):197-205. PubMed ID: 10022355
[TBL] [Abstract][Full Text] [Related]
11. Marked increase in membranolytic selectivity of novel cyclic tachyplesins constrained with an antiparallel two-beta strand cystine knot framework.
Tam JP; Lu YA; Yang JL
Biochem Biophys Res Commun; 2000 Jan; 267(3):783-90. PubMed ID: 10673369
[TBL] [Abstract][Full Text] [Related]
12. Analysis of sequence requirements for biological activity of cyanovirin-N, a potent HIV (human immunodeficiency virus)-inactivating protein.
Mori T; Shoemaker RH; Gulakowski RJ; Krepps BL; McMahon JB; Gustafson KR; Pannell LK; Boyd MR
Biochem Biophys Res Commun; 1997 Sep; 238(1):218-22. PubMed ID: 9299482
[TBL] [Abstract][Full Text] [Related]
13. Design and synthesis of cyclic disulfide-bonded antibacterial peptides on the basis of the alpha helical domain of Tenecin 1, an insect defensin.
Ahn HS; Cho W; Kim JM; Joshi BP; Park JW; Lohani CR; Cho H; Lee KH
Bioorg Med Chem; 2008 Apr; 16(7):4127-37. PubMed ID: 18243710
[TBL] [Abstract][Full Text] [Related]
14. Extension of the polyanionic cosalane pharmacophore as a strategy for increasing anti-HIV potency.
Cushman M; Insaf S; Paul G; Ruell JA; De Clercq E; Schols D; Pannecouque C; Witvrouw M; Schaeffer CA; Turpin JA; Williamson K; Rice WG
J Med Chem; 1999 May; 42(10):1767-77. PubMed ID: 10346929
[TBL] [Abstract][Full Text] [Related]
15. Structural characterization of the cyclic cystine ladder motif of θ-defensins.
Conibear AC; Rosengren KJ; Harvey PJ; Craik DJ
Biochemistry; 2012 Dec; 51(48):9718-26. PubMed ID: 23148585
[TBL] [Abstract][Full Text] [Related]
16. A peptidomimetic HIV-entry inhibitor directed against the CD4 binding site of the viral glycoprotein gp120.
Neffe AT; Meyer B
Angew Chem Int Ed Engl; 2004 May; 43(22):2937-40. PubMed ID: 15170309
[No Abstract] [Full Text] [Related]
17. Click chemistry on azidoproline: high-affinity dual antagonist for HIV-1 envelope glycoprotein gp120.
Gopi HN; Tirupula KC; Baxter S; Ajith S; Chaiken IM
ChemMedChem; 2006 Jan; 1(1):54-7. PubMed ID: 16892335
[No Abstract] [Full Text] [Related]
18. NMR solution structure of a potent cyclic nonapeptide inhibitor of ICAM-1-mediated leukocyte adhesion produced by homologous amino acid substitution.
Sillerud LO; Burks EJ; Brown WM; Brown DC; Larson RS
J Pept Res; 2004 Oct; 64(4):127-40. PubMed ID: 15357668
[TBL] [Abstract][Full Text] [Related]
19. θ-Defensins: cyclic peptides with endless potential.
Lehrer RI; Cole AM; Selsted ME
J Biol Chem; 2012 Aug; 287(32):27014-9. PubMed ID: 22700960
[TBL] [Abstract][Full Text] [Related]
20. A minor beta-structured conformation is the active state of a fusion peptide of vesicular stomatitis virus glycoprotein.
Sarzedas CG; Lima CS; Juliano MA; Juliano L; Valente AP; Da Poian AT; Almeida FC
J Pept Sci; 2008 Apr; 14(4):429-35. PubMed ID: 17985397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
